Floatz logo

NEPENTHE

Liver Transplantation

The Cleveland ClinicSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Liver Transplantation cohort.

Asset / SponsorPhaseRating
TACROLIMUS
The Second Hospital of Tangshan
Phase 4BBB
Monomethyl Fumarate
Southern Medical University, China
Phase 4BB
Equine Atg
University Hospital, Toulouse
Phase 4BB
Rebetol
Merck Sharp & Dohme LLC
Phase 3BB
Rapamycin
Melanoma and Skin Cancer Trials Limited
Phase 3BB

View all 19 →

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →